The formation of Nuovo Biologics represents several years of research and development exploring new broad spectrum antiviral, as well as oncology, technologies. Founded in 2010 and based in Florida, the Company is commercializing an innovative set of protein drugs. Our first drug formulation is “PVX”, which appears to treat a broad spectrum of viral infections, including those caused by herpes, influenza, and particular retroviruses; another, “MMX”, for specific malignant tumors. Both drugs are expected to be effective across animal species, and possibly, in humans.